Actuate Therapeutics, Inc. Cash and Restricted Cash
Actuate Therapeutics, Inc. (ACTU) had Cash and Restricted Cash of $4.43 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.43M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.13M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $13.16M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $16.92M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $4.43M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $8.13M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $13.16M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $16.92M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $6.49M 10-Q · filed 2026-08-14 |
| 2025-03-31 | $3.89M 10-Q · filed 2026-05-14 |
| 2024-12-31 | $8.64M 10-Q · filed 2026-08-14 |
| 2024-09-30 | $13.52M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $351.71K 10-Q · filed 2025-08-14 |
| 2024-03-31 | $2.07M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $2.96M 10-K · filed 2026-03-26 |
| 2023-09-30 | $8.47M 10-Q · filed 2024-11-13 |
| 2023-06-30 | $14.11M 10-Q · filed 2024-09-24 |
| 2022-12-31 | $20.45M 10-K · filed 2025-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B |